Jan. 28, 2026 — Corify Care has announced a major development in cardiac electrophysiology with the publication of its ...
Jan. 28, 2026 — Imperative Care has announced the commercial launch and first patient cases of the new Zoom 4S Catheter ...
Jan. 27. 2026 — Circle Cardiovascular Imaging Inc. has announced the release of cvi42 v6.4, the latest version of its ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Jan. 27, 2026 — BURL Concepts, a private company developing a rapid, automated and affordable test for evaluating ...
Jan. 27, 2026 — Cytokinetics, Inc. has announced that Myqorzo (aficamten) is now available for prescription in 5 mg, 10 ...
Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Jan. 27, 2026 — Robocath has launched the world’s first FIH (First-In-Human) clinical study evaluating its new robotic ...
Jan. 26, 2026 — AISAP, a provider of AI point-of-care diagnostics, has published a new clinical study in the peer ...
Jan. 11, 2026 — The Global Refurbished Medical Imaging Equipment Market Size is projected to grow at a CAGR of 15.07% ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...
Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...
Jan. 20, 2026 — Polarean, a commercial-stage medical imaging company advancing functional MRI of the lungs, has expanded ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
On Feb. 19, at 7 p.m. eastern time, Cleerly will present a live webinar on “Women's Heart Health: Uncovering Hidden ...
Jan. 15, 2026 — Boston Scientific Corp. and Penumbra, Inc. have entered into a definitive agreement under which Boston ...
Jan. 16, 2026 — MemorialCare Heart & Vascular Institute has launched the FDA-approved Symplicity Renal Denervation (RDN) ...
January 29, 2026
